Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Live Attenuated Influenza Vaccine on Experimental Human Pneumococcal Colonisation
2014-004634-26Phase 4Completed
- Sponsor
- Royal Liverpool University Hospital
- Start
- Apr 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of live attenuated influenza vaccine and Fluarix Quadrivalent in influenza and Pneumococcal carriage (NPC) (3 arms), sponsored by Royal Liverpool University Hospital. Primary endpoint: Pneumococcal colonisation detection. Started Apr 2015; status: completed.
02
Drugs
live attenuated influenza vaccineFluarix Quadrivalent
03
Conditions
influenzaPneumococcal carriage (NPC)
Beyond the preview
Go deeper on 2014-004634-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004634-26.